Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands

Details for Australian Patent Application No. 2002252009 (hide)

Owner AVENTIS PHARMACEUTICALS INC.

Inventors Weiberth, Franz, Jr.; Shutske, Gregory; Gill, Harpal; Hemmerle, Horst; Hendrix, James, A.; Jurcak, John, G.; Zhao, Xu-Yang; Bordeau, Kenneth, J.; Urmann, Matthias; Mueller, Paul, J.; Jackson, Sharon, A.; Nieduzak, Thaddeus; Strupczewski, Joseph, T.

Agent Watermark

Pub. Number AU-A-2002252009

PCT Pub. Number WO2002/066469

Priority 60/269,253 16.02.01 US; 0117531.4 19.07.01 GB

Filing date 15 February 2002

Wipo publication date 4 September 2002

International Classifications

C07D 409/00 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

27 February 2003 Application Open to Public Inspection

  Published as AU-A-2002252009

12 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002252010-DRUG METABOLIZING ENZYMES

2002252008-EXTREME ULTRAVIOLET MASK WITH IMPROVED ABSORBER